| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Tilorone |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Non-steroidal anti-inflammatory agent (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Cromoglicic acid |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| forgiftning med lokalt anti-inflammatorisk lægemiddel |
Causative agent |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Valdecoxib (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Budesonide (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Halcinonide (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Alclometasone (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Clobetasone (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Mometasone (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Deflazacort (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Fluticasone propionate (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Fluticasone (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| leverderivatkompleks |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| tørret lever-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| injicerbart leverpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing liver extract (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Hepacon liver extract D 0.1mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Topical anti-inflammatory prep[1] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Topical anti-inflammatory prep[2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Other preps for inflamed joints |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Antiinflammatoriske præparater |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| leverderivatkompleks 25,5 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Ciclesonide (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| etanercept 25 mg pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| adalimumab 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing tumor necrosis factor alpha inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromoglycat 20 mg inhalationspulver kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromglycat 20 mg/2 ml nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromglycat 5 mg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromglycatinhalator a 5 mg + spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromglycat 5 mg indåndingsudløst inhalationsaerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromoglycat + albuterol 1 mg/100 µg inhalator + spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromoglycat 1 mg + albuterol 100 µg inhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning a 100 mg/5 ml peroralt koncentrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromglycat + isoprenalinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromoglycat + albuterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromoglycat 2 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromglycat til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| inhaleret natriumcromglycat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromglycat til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing cromoglicic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Sodium cromoglycate [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Sodium cromoglycate [asthma] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Sodium cromoglycate compounds |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Sodium cromoglycate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Sodium cromoglycate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning a 20 mg/2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriuminhalator a 0,8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning 20 mg ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumgas a 100 mg/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumsprayopløsning 5,2 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning a 10 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriuminhalator a 800 µg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumsprayopløsning a 40 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumspray a 8,1 g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumopløsning a 40 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| cromolynnatriumspray a 0,8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| oftalmisk cromolynnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| etanercept 50 mg pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| natriumcromoglycat + xylometazolinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Tumor necrosis factor alpha inhibitor |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| Liver extract (substance) |
Is a |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| forgiftning med lokalt antiinfektiøst og antiinflammatorisk middel |
Causative agent |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
| antiinflammatorisk ørepræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antiinflammatorisk middel |
Inferred relationship |
Some |
|
FHIR